Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
281 - 290 of 892 results
  • Abstract
    In vivo chronic cannabinoid administration impairs spontaneous network activity of cerebellar granule neurons.
    Acute administration of delta9-tetrahydrocannabinol (THC), the psychoactive ingredient of marihuana, produces dose-dependent locomotor effects that are selectively mediated by activation of CB1 cannabinoid receptors. CB1 receptors are highly expressed in motor control brain regions, such as basal ganglia and cerebellum and modulate synapses between cerebellar granule cells (GC) and Purkinje cells. Chronic THC can induce physical dependence that implicates the cerebellum and THC withdrawal syndrome has an important motor component. However, the neurophysiological adaptive mechanisms occuring during chronic THC treatment and withdrawal remain unexplored. We aimed to evaluate the effects of chronic THC administration and withdrawal on GC neuronal activity using calcium imaging techniques. We first examined the effects of acute and chronic THC on spontaneous neuronal activity patterns of cerebellar GCs circuits. In order to evaluate the effects of THC withdrawal syndrome on these activity patterns, the selecti...
    Nov 14, 2001
  • Abstract
    Differential role of phyto-, synthetic- and endocannabinoids in Absence Epilepsy
    The use of medical/recreational marijuana and its legal market size are on the rise worldwide. Medical Marijuana has potential benefits for different diseases, but the lack of biomedical research and its popularity based on anecdotal evidence poses a ri...
    Nov 11, 2021
  • Abstract
    Effect of GPR55 inhibition into the external globus pallidus on fine motor skills in hemiparkinsonian rats
    Previous reports have shown that both cannabidiol (CBD) and CID16020040 blocks the GPR55-mediated effects of LPI. In addition, the expression of GPR55 mRNA in the basal ganglia (BG) has been described by in situ hybridization, especially in the striatum...
    Nov 10, 2021
  • Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances | Journal of Neuroscience
    There remains debate regarding the impact of cannabis on neuropsychiatric disorders. Here, we examined the effects of cannabidiol (CBD), a nonpsychoactive constituent of cannabis, on heroin self-administration and drug-seeking behavior using an experimental rat model. CBD (5–20 mg/kg) did not alter stable intake of heroin self-administration, extinction behavior, or drug seeking induced by a heroin prime injection. Instead, it specifically attenuated heroin-seeking behavior reinstated by exposure to a conditioned stimulus cue. CBD had a protracted effect with significance evident after 24 h and even 2 weeks after administration. The behavioral effects were paralleled by neurobiological alterations in the glutamatergic and endocannabinoid systems. Discrete disturbances of AMPA GluR1 and cannabinoid type-1 receptor expression observed in the nucleus accumbens associated with stimulus cue-induced heroin seeking were normalized by CBD treatment. The findings highlight the unique contributions of distinct canna...
    Nov 25, 2009 Yanhua Ren
  • Abstract
    Pretreatment with ondansetron or delta-9-tetrahydrocannabinol interferes with the establishment of lithium-induced taste avoidance in the house musk shrew (Suncus murinus).
    Recent evidence suggests that toxin-induced taste avoidance in the non-emetic rat is not mediated by conditioned sickness. However, it is possible that toxin-induced taste avoidance in an emetic species is mediated by conditioned sickness. The present experiments evaluated the potential of the anti-emetic agents, ondansetron (OND) and delta-9-tetrahydrocannabinol (THC) to interfere with lithium (LiCl)-induced taste avoidance in the house musk shrew (Suncus murinus). In Experiment 1, shrews were pretreated with OND (1.5 mg/kg) or Saline 30 min prior to drinking 0.1% saccharin solution then they were injected with LiCl (390 mg/kg) or saline. When assessed by a two-bottle test over a 12 hr period, but not a one bottle test, the shrews displayed a LiCl-induced saccharin avoidance that was prevented by pretreatment with OND. The relatively weak effects may have been due to floor effects in consumption of saccharin solution; therefore a highly preferred 32% sucrose solution was used in another experiment. In Exp...
    Oct 27, 2004
  • Abstract
    Endogenous and exogenous cannabinoids potentiate glycine receptor-mediated responses through a CB receptor independent mechanism in Xenopus oocytes.
    Anandamide and delta 9-tetrahydrocannabinol (THC) are endogenous and exogenous ligands for cannabinoid (CB) receptors. While most of anandamide and THC actions are thought to be mediated through endogenous cannabinoid type1 (CB1) receptors, there is evidence that some of cannabinoid-induced behaviors are independent of CB1 receptors. Here, we report that both anandamide and THC increased the amplitude of current activated by glycine in Xenopus oocytes expressing human homomeric and heromeric glycine receptors in a concentration-dependent manner over a concentration range from 30 to 3000 nM. The EC50 values of the THC and ANA concentration-response curves were 86 ± 9 nM and 319 ± 10 nM for the α1 subunits; and 73 ± 8 nM and 318 ± 14 nM for the α1β1 subunits. ANA and THC did not alter GABAA receptor-mediated responses, suggesting that the potentiation by ANA and THC is specific for the glycine receptors. The maximum potentiation by ANA and THC was observed at the lowest concentration of glycine. With increas...
    Nov 15, 2005
  • Abstract
    Developmental exposure to cannabinoids increases subsceptibility to ethanol-induced apoptotic neurodegeneration in the neonatal rat brain.
    Marijuana is the most widely used illicit drug among women of reproductive age. Neurocognitive deficits have been reported in children whose mothers used marijuana during pregnancy. Maternal consumption of alcohol during pregnancy has long been known to cause serious developmental deficits depending on the amount and timing of exposure during gestation. Here we report that acute administration of Δ9-tetrahydrocannabinol (THC, 1-10 mg/kg), the principal psychoactive cannabinoid of marijuana, has pro-apoptotic properties in the neonatal rat brain when co-administered with a subtoxic dose of ethanol (1.1 g/kg). THC did not induce neurodegeneration when administered alone. Neuronal degeneration became disseminated and very severe when THC was combined with a mildly intoxicating ethanol dose (1.5 g/kg), with the effect of this drug combination qualitatively and quantitatively resembling the massive apoptotic death observed when administering ethanol alone at much higher doses. THC did not influence plasma ethan...
    Oct 26, 2004
  • Abstract
    Tolerance, dependence and motivational responses to cannabinoids in μ, δ, or κ opioid receptor knockout mice.
    Cross-interactions between opioid and cannabinoid systems in dependence and reward-related processes have been shown in many studies. We have recently established in mice a model of tolerance and dependence to Δ9-tetrahydrocannabinol (THC) as well as a model of place conditioning to evaluate both rewarding and aversive properties of THC. These two models represent useful tools for the study of the neurobiological basis of THC actions. We have now used these models in three strains of knockout mice lacking either μ, δ or κ opioid receptors, to determine the implication of each opioid receptor in tolerance and dependence to THC as well as in the motivational effects induced by this compound. In each strain of knockout mice, we first studied the rewarding and aversive effects of THC (1 and 5 mg/kg) in the place conditioning paradigm. We then studied the development of tolerance to the antinociceptive, hypothermic, and hypolocomotor effects of THC during chronic treatment (20 mg/kg, twice daily). Finally, THC-...
    Nov 5, 2000
  • Abstract
    Acute delta-9-tetrahydrocannabinol activates A9/A10 dopamine neurons in non-human primates as indicted by expression of c-Fos.
    Delta-9-tetrahydrocannabinol (THC) is the major psychoactive constituent of marijuana and is thought to be responsible for acute and long-term behavioral effects seen in humans potentially through a dysfunction of the frontal cortex. In the rat, acute exposure to THC increases cortical dopamine (DA) turnover and disrupts short-term memory (Neuropsychopharm 16:426-432, 1997). In this current study, we examined the effects of a single dose of THC on midbrain DA neurons in non-human primates using the immediate-early gene, c-fos, as an indicator of the initiation of long-term adaptation brought on by acute activation. Twelve male, adult African green monkeys of St Kitts origin (Cercopithecus aethiops sabaeus) were given a single injection of vehicle or THC, 1.25 mg/kg or 2.5 mg/kg. After 1 hour, the monkeys were overdosed on pentobarbital, perfused with saline, and the brains were placed in 4% formalin for 24 hours. The midbrains were cut into 50 μm sections and stained for Fos-immunoreactivity (Fos-ir) and t...
    Nov 11, 2003
  • Abstract
    Intra-PFC infusion of cannabidiol induces impairments in cognitive flexibility measured in a set-shifting task through serotonergic 5-HT1a receptor transmission
    The prefrontal cortex (PFC) regulates multiple psychological processes including anxiety, sociability, attention, flexibility and cognition. Considerable evidence underscore its critical role in the development of various types of psychiatric disorders ...
    Nov 11, 2017
  • Previous
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience